(NICE) Nice - Ratings and Ratios
CXone, Enlighten, Smart Self-Service, Journey Orchestration, Evidence Management
NICE EPS (Earnings per Share)
NICE Revenue
Description: NICE Nice
NICE Ltd. is a global provider of cloud-based AI-driven solutions for customer experience, financial crime, and compliance. The companys flagship product, CXone, is an open, cloud-native platform that enables organizations to deliver personalized customer experiences. NICEs AI-powered solutions, such as Enlighten and smart self-service, help businesses automate and optimize customer interactions, while its X-Sight and Xceed platforms provide comprehensive anti-money laundering (AML) and fraud prevention capabilities.
NICEs product suite is designed to help organizations turn raw data into actionable intelligence, detect and prevent financial crimes, and adhere to regulatory compliance requirements. The companys digital evidence management platform, Evidencentral, is used by public safety and law enforcement agencies worldwide. With a strong presence in the application software industry, NICE has established itself as a leader in the use of AI and analytics to drive business outcomes.
Analyzing the technical data, NICEs stock price has been trending upwards, with a current price of $175.96, above its 20-day and 50-day simple moving averages (SMA). The stocks average true range (ATR) is 2.68%, indicating moderate volatility. Given the current fundamental data, including a market capitalization of $10.49B and a forward P/E ratio of 13.11, we can forecast that NICEs stock price may continue to rise as the company continues to execute on its growth strategy and expand its market share in the application software industry.
Using a combination of technical and fundamental analysis, we can predict that NICEs stock price may reach $200 in the next 6-12 months, driven by the companys strong product portfolio, increasing demand for AI-driven solutions, and improving profitability. The companys return on equity (RoE) of 13.19% indicates a strong ability to generate profits from shareholder equity, supporting our forecast. However, investors should be aware of potential risks, including competition in the application software industry and regulatory changes that may impact NICEs business.
Additional Sources for NICE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
NICE Stock Overview
Market Cap in USD | 10,618m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Application Software |
IPO / Inception | 1996-01-24 |
NICE Stock Ratings
Growth Rating | -36.5 |
Fundamental | 61.5 |
Dividend Rating | 6.67 |
Rel. Strength | -12.7 |
Analysts | 4.33 of 5 |
Fair Price Momentum | 147.26 USD |
Fair Price DCF | 96.44 USD |
NICE Dividends
Currently no dividends paidNICE Growth Ratios
Growth Correlation 3m | 82.3% |
Growth Correlation 12m | -48.2% |
Growth Correlation 5y | -73% |
CAGR 5y | -1.93% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | 0.54 |
Alpha | -17.16 |
Beta | 1.238 |
Volatility | 31.83% |
Current Volume | 204.6k |
Average Volume 20d | 385.1k |
As of July 04, 2025, the stock is trading at USD 170.19 with a total of 204,596 shares traded.
Over the past week, the price has changed by +1.73%, over one month by +1.81%, over three months by +6.79% and over the past year by -0.67%.
Yes, based on ValueRay´s Fundamental Analyses, Nice (NASDAQ:NICE) is currently (July 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.51 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NICE is around 147.26 USD . This means that NICE is currently overvalued and has a potential downside of -13.47%.
Nice has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy NICE.
- Strong Buy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, NICE Nice will be worth about 175.5 in July 2026. The stock is currently trading at 170.19. This means that the stock has a potential upside of +3.12%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 213.5 | 25.4% |
Analysts Target Price | 211 | 24% |
ValueRay Target Price | 175.5 | 3.1% |